No. 21-406

Impax Laboratories, Inc. v. Federal Trade Commission

from the United States Court of Appeals for the Fifth Circuit

See other cases from the Fifth Circuit.

Docket Entries

Petition DENIED.

Reply of petitioner Impax Laboratories, Inc. filed. (Distributed)

Reply of Impax Laboratories, Inc. not accepted for filing. (November 23, 2021)

DISTRIBUTED for Conference of 12/10/2021.

Waiver of the 14-day waiting period under 15.5 filed.

Brief of respondent Federal Trade Commission in opposition filed.

Brief amicus curiae of Association for Accessible Medicines filed.

Motion to extend the time to file a response is granted and the time is extended to and including November 15, 2021.

Motion to extend the time to file a response from October 15, 2021 to November 15, 2021, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due October 15, 2021)


Impax Laboratories, Inc., Petitioner, represented by Jay Philip Lefkowitz

United States, Respondent, represented by Elizabeth B. Prelogar

Amici Curiae

Association for Accessible Medicines, Amicus Curiae, represented by Brian Timothy Burgess

Last updated: May 17, 2024